Everbright Biofund
Overview
Everbright Biofund is a venture capital firm that provides funding to globally promising biomedical startups with a focus on MedTech, BioTech, and HealthTech.
Portfolio Companies
3
Website
everbrightbio.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Iambic Therapeutics | Nov 2025 | VC Round | Co-investor |
| Syncell | Jul 2025 | Series A | Co-investor |
| Infinimmune | Aug 2026 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Everbright Biofund based?
Everbright Biofund is headquartered in Taiwan.
When was Everbright Biofund founded?
Founding year information for Everbright Biofund is not publicly available.
How many portfolio companies does Everbright Biofund have?
Everbright Biofund has 3 portfolio companies in Caplight's dataset.
What are some companies in Everbright Biofund's portfolio?
Portfolio companies visible on Caplight include Iambic Therapeutics, Syncell, Infinimmune.
What was Everbright Biofund's most recent investment shown here?
Everbright Biofund's most recent investment in this portfolio sample was in Infinimmune in 2026.
What sectors does Everbright Biofund focus on?
Everbright Biofund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Everbright Biofund focus on?
Everbright Biofund typically invests at the Mid stage.